Dow Up0.64% Nasdaq Up0.68%

Synageva BioPharma Corp. (GEVA)

-NasdaqGS
64.57 Down 0.04(0.06%) Sep 18, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 2,343   1,586   3,474   1,369  
Cost of Revenue -   -   -   -  
Gross Profit 2,343   1,586   3,474   1,369  
Operating Expenses
Research Development39,528  27,868  25,176  22,676  
Selling General and Administrative12,591  9,804  8,866  6,597  
Non Recurring -   -   -   -  
Others537  390  376  292  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (50,313) (36,476) (30,944) (28,196)
Income from Continuing Operations
Total Other Income/Expenses Net89  70  (86)73  
Earnings Before Interest And Taxes(50,224)(36,406)(30,688)(28,123)
Interest Expense -   -   -   -  
Income Before Tax(50,224)(36,406)(30,688)(28,123)
Income Tax Expense16  18   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(50,240)(36,424)(30,736)(28,123)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (50,240) (36,424) (30,736) (28,123)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (50,240) (36,424) (30,736) (28,123)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.